Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Real-world outcomes of Mantle Cell Lymphoma in Colombia: A multicenter cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMaría Angelina PérezMTMaría TamayoGAGabriel Ayala

Discussion

Loading...

Member takes

Overview

Multicenter cohort study finds 66.2% overall survival in MCL patients, suggesting treatment barriers persist in Colombia.

Key Points

  • This study aims to characterize clinical features, treatment access, and survival outcomes in patients with mantle cell lymphoma in Colombia.
  • Performed a retrospective cohort study of 80 MCL patients from two hospitals in Bogotá.
  • Collected data on baseline characteristics, treatment patterns, and survival outcomes.
  • Analyzed overall survival using Kaplan-Meier estimates and log-rank tests.
  • Median age of participants was 65 years, with 72.5% male.
  • 5-year overall survival rate was 66.2%, with the highest rate in classical MCL at 76.2%.
  • Fewer than one-third of eligible patients underwent autologous stem cell transplantation, highlighting access barriers.

Cite This Study

Pérez et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d200https://doi.org/10.1182/blood-2025-7102
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world treatment and outcomes of Mantle Cell Lymphoma in Latin America: A multinational cohort analysis2025
  2. 2Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience2025 · 1 citations
  3. 3Treatment patterns and survival outcomes in patients with Mantle Cell Lymphoma: Interim report of the Asia-Pacific multinational prospective registry study2025 · 1 citations
  4. 4Real-world treatment and safety outcomes of patients with Mantle Cell Lymphoma in the United States2025
  5. 5Initial treatment patterns and survival outcomes in patients with Mantle Cell Lymphoma in the era of BTK inhibitors: A multicenter real-world study2025